Alekseev, S M, N.N.Petrov Research Institute of Oncology of the Ministry of Health of the Russian Federation

Issue Section Title Abstract File
Vol 18, No 2 (2016) Articles Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study Abstract PDF

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies